Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -21.48%49.35B | 6.62%278.09B | 14.82%62.85B | 35.21%260.83B | 40.49%71.45B | 58.69%72.32B | 23.88%62.32B | 18.55%54.73B | -4.96%192.91B | -19.31%50.86B |
| Cost of revenue | -24.67%42.33B | 8.42%252B | 14.85%56.19B | 37.83%232.43B | 40.09%63.99B | 62.23%64.63B | 24.10%54.89B | 25.78%48.92B | -7.42%168.64B | -19.35%45.68B |
| Gross profit | 5.48%7.02B | -8.11%26.09B | 14.58%6.66B | 16.99%28.39B | 43.96%7.46B | 34.11%7.69B | 22.23%7.44B | -20.11%5.81B | 16.46%24.27B | -18.98%5.18B |
| Operating expense | 11.91%6.35B | 8.38%23.5B | 15.81%5.68B | 11.15%21.68B | 26.70%6.2B | 26.36%5.46B | -3.67%5.12B | -1.51%4.9B | 9.11%19.5B | 1.18%4.89B |
| Operating profit | -31.73%669M | -61.38%2.59B | 7.93%980M | 40.89%6.71B | 335.17%1.26B | 57.83%2.23B | 201.43%2.32B | -60.44%908M | 60.78%4.76B | -81.42%290M |
| Net non-operating interest income (expenses) | -177.08%-185M | -20.28%397M | 126.42%240M | 498M | 285.71%130M | 313.95%178M | 950.00%84M | 457.89%106M | 0 | -216.67%-70M |
| Non-operating interest income | -26.28%317M | 23.48%1.67B | 51.94%430M | 45.79%1.35B | 46.72%380M | 79.40%357M | 27.41%330M | 35.41%283M | 40.52%926M | 15.63%259M |
| Non-operating interest expense | 164.21%502M | 49.06%1.27B | 7.34%190M | -7.99%852M | -24.01%250M | 14.74%179M | -1.99%246M | -6.84%177M | 94.54%926M | 100.61%329M |
| Net investment income | -771.43%-235M | -284.19%-571M | -95.20%35M | 135.11%310M | 1,993.10%549M | 18.93%-694M | -104.48%-274M | 436.03%729M | -378.55%-883M | -122.83%-29M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 301M | 0 | ||||||||
| Income from associates and other participating interests | 44.67%868M | 834.53%4.11B | 455.56%600M | -158.80%-559M | -50.72%206M | -676.79%-646M | -2,622.22%-227M | 114.30%108M | 10.00%-216M | 222.22%418M |
| Special income (charges) | 0 | -128.91%-1.38B | 1M | 4.79B | 0 | |||||
| Less:Restructuring and mergern&acquisition | --0 | ---4.16B | ---4.16B | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | ---- | ---- | ---4.16B | ---6.64B | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | ---- | -25.14%1.39B | ---- | --1.85B | ---- | ---- | ---- | ---- | --0 | ---- |
| Less:Negative goodwill immediately recognized | --0 | --4.15B | --4.15B | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 433.33%96M | -280.56%-65M | 172.00%18M | -83.93%36M | -471.05%-282M | 217.14%41M | 162.61%302M | -136.76%-25M | 330.93%224M | 180.85%76M |
| Income before tax | -35.27%1.21B | -56.92%5.08B | 2.63%1.87B | 203.03%11.78B | 872.37%6.65B | 63.22%1.11B | 187.58%2.2B | 3.63%1.83B | 24.38%3.89B | -47.79%684M |
| Income tax | -18.65%650M | 55.69%3.02B | 43.71%799M | -12.84%1.94B | -116.37%-91M | -1.55%381M | 90.77%1.1B | -21.69%556M | 49.66%2.23B | -38.15%556M |
| Net income | -47.63%563M | -79.14%2.05B | -15.35%1.08B | 492.41%9.84B | 5,126.36%6.74B | 150.17%723M | 478.53%1.11B | 20.72%1.27B | 1.40%1.66B | -68.69%129M |
| Net income continuous operations | -47.63%563M | -79.13%2.05B | -15.35%1.08B | 492.47%9.84B | 5,167.19%6.74B | 149.66%724M | 478.53%1.11B | 20.72%1.27B | 1.40%1.66B | -68.86%128M |
| Noncontrolling interests | 0.00%3M | 68.42%32M | 200.00%3M | 35.71%19M | -20.00%4M | 66.67%5M | 200.00%9M | -66.67%1M | -17.65%14M | -68.75%5M |
| Net income attributable to the company | -47.81%559M | -79.43%2.02B | -15.54%1.07B | 496.30%9.82B | 5,333.87%6.74B | 150.52%719M | 482.98%1.1B | 20.99%1.27B | 1.67%1.65B | -68.61%124M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -47.81%559M | -79.43%2.02B | -15.54%1.07B | 496.30%9.82B | 5,333.87%6.74B | 150.52%719M | 482.98%1.1B | 20.99%1.27B | 1.67%1.65B | -68.61%124M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -47.76%9.55 | -79.42%34.49 | -15.53%18.28 | 496.19%167.59 | 5,323.58%114.98 | 150.72%12.26 | 482.87%18.71 | 20.96%21.64 | 1.66%28.11 | -68.55%2.12 |
| Diluted earnings per share | -47.76%9.55 | -79.42%34.49 | -15.53%18.28 | 496.19%167.59 | 5,333.86%114.98 | 150.72%12.26 | 482.98%18.7026 | 20.96%21.64 | 1.66%28.11 | -68.61%2.116 |
| Dividend per share | 0 | 108.33%25 | 0 | 12 | 12 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |